Moderna Exceeds Revenue Estimates on International Sales
Moderna reported first-quarter revenue of $389 million, beating estimates behind strong international sales. The firm maintained its 2026 growth forecast.
Xurve View
Insights:
Xurve View
MODERNA INC reported first-quarter revenue of $389 million, exceeding analyst estimates of $228 million on strong international vaccine sales. International revenue reached $311 million, fueled by partnerships in the United Kingdom, Canada, and Australia. The shift toward global markets offsets declining demand in the United States following recent regulatory and policy changes.
